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myloid 
 
 
 
-peptide (A
 
 
 
) is generated by the consecutive
cleavages of 
 
 
 
- and 
 
 
 
-secretase. The intramem-
braneous 
 
 
 
-secretase cleavage critically depends on
the activity of presenilins (PS1 and PS2). Although there is
evidence that PSs are aspartyl proteases with 
 
 
 
-secretase
activity, it remains controversial whether their subcellular
localization overlaps with the cellular sites of A
 
 
 
 production.
We now demonstrate that biologically active GFP-tagged
PS1 as well as endogenous PS1 are targeted to the plasma
membrane (PM) of living cells. On the way to the PM, PS1
binds to nicastrin (Nct), an essential component of the
 
 
 
-secretase complex. This complex is targeted through the
A
 
secretory pathway where PS1-bound Nct becomes endogly-
cosidase H resistant. Moreover, surface-biotinylated Nct can
be coimmunoprecipitated with PS1 antibodies, demonstrating
that this complex is located to cellular sites with 
 
 
 
-secretase
activity. Inactivating PS1 or PS2 function by mutagenesis
of one of the critical aspartate residues or by 
 
 
 
-secretase
inhibitors results in delayed reinternalization of the 
 
 
 
-amyloid
precursor protein and its accumulation at the cell surface.
Our data suggest that PS is targeted as a biologically active
complex with Nct through the secretory pathway to the
cell surface and suggest a dual function of PS in 
 
 
 
-secretase
processing and in trafﬁcking.
 
Introduction
 
The two presenilins (PSs),* PS1 and PS2, are key factors in the
pathogenesis of Alzheimer’s disease (for review see Esler and
Wolfe, 2001). Familial Alzheimer’s disease (FAD)–associated
PS mutations drastically lower the age of onset of the disease.
Currently, 
 
 
 
100 mutations (see http://molgen-www.uia.ac.be/
ADMutations) have been identified, which apparently all cause
the increased production of the highly amyloidogenic 42–
amino acid amyloid 
 
 
 
-peptide (A
 
 
 
42) (Selkoe, 1999).
Amyloid 
 
 
 
-peptide (A
 
 
 
) is generated from the 
 
 
 
-amyloid
precursor protein (
 
 
 
APP) by proteolytic processing mediated
by two distinct secretase activities (Esler and Wolfe, 2001).
 
 
 
-secretase (
 
 
 
-site APP cleaving enzyme [BACE]) mediates
the NH
 
2
 
-terminal cleavage (Vassar and Citron, 2000) and
produces a membrane-bound COOH-terminal fragment of
 
 
 
APP (
 
 
 
APP CTF). BACE has an acidic pH optimum and
is preferentially active within early endosomes (for review see
Vassar and Citron, 2000). Consistent with the acidic pH
optimum of BACE, reinternalization of 
 
 
 
APP from the cell
surface is required for A
 
 
 
 generation (Perez et al., 1999).
The BACE-generated 
 
 
 
APP CTF can be transported back
to the cell surface (Yamazaki et al., 1996), and at or close to
the cell surface, the final 
 
 
 
-secretase cleavage takes place,
which results in the liberation of A
 
 
 
 into biological fluids
(for review see Selkoe, 1999).
Although 
 
 
 
-secretase has been identified (Vassar and Citron,
2000), the nature of 
 
 
 
-secretase is still unknown. Clearly,
PSs are required for the intramembraneous 
 
 
 
-secretase cleavage.
Gene deletion of PS1 and PS2 fully inhibits 
 
 
 
-secretase activity
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and results in the accumulation of the immediate precursors
for 
 
 
 
-secretase activity, the 
 
 
 
APP CTF, as well as in a com-
plete loss of A
 
 
 
 production (Herreman et al., 2000; Zhang et
al., 2000). PS inactivation by the mutagenesis of critical as-
partates within TM6 and TM7 of PS1 (Wolfe et al., 1999b)
and PS2 (Steiner et al., 1999a; Kimberly et al., 2000) also
blocks 
 
 
 
-secretase activity. In addition, the critical aspartate
in transmembrane domain 7 is located within a conserved
domain also found in numerous bacterial aspartyl proteases
of the type 4 prepilin peptidase family (Steiner et al., 2000).
Therefore, it is tempting to speculate that PSs are aspartyl
proteases with 
 
 
 
-secretase activity (Wolfe et al., 1999a). This
is also consistent with the finding that inactivation of PSs
blocks the intramembraneous cleavage of its other known
substrates, Notch 1–4 (De Strooper et al., 1999; Saxena et
al., 2001), ErbB4 (Ni et al., 2001), E-cadherin (Marambaud
et al., 2002), and LDL receptor–related protein (May et al.,
2002). Although this is the most parsimonious conclusion
from the above described results, PSs are probably not active
by themselves but require the formation of a proteolytically
active high molecular weight complex (Capell et al., 1998; Li
et al., 2000a). Moreover, the subcellular localization of PSs
may not overlap with cellular compartments thought to be
involved in A
 
 
 
 production, i.e., where 
 
 
 
-secretase activity re-
sides (Annaert et al., 1999; Cupers et al., 2001). This phe-
nomenon, now known as the “spatial paradox” (Checler,
2001; Cupers et al., 2001), describes the findings that PSs are
predominantly located within early compartments such as
the ER and the intermediate compartment (Annaert et al.,
1999; Cupers et al., 2001). Careful cellular analysis of PS1
distribution in cultured neurons indeed revealed very little, if
any, PS1 beyond these early compartments (Annaert et al.,
1999; Cupers et al., 2001). Based on these findings, it was
concluded that PSs may not be identical to 
 
 
 
-secretase (An-
naert et al., 1999; Cupers et al., 2001), because this protease
is thought to be active at or close to the cell surface (Haass et
al., 1993). However, a number of studies have found PSs to
be localized in post-Golgi compartments (Takashima et al.,
1996; Efthimiopoulos et al., 1998; Georgakopoulos et al.,
1999; Ray et al., 1999; Schwarzman et al., 1999; Lah and
Levey, 2000; Singh et al., 2001).
Recently, nicastrin (Nct) was shown to be a component of
the PS complex that is essential for 
 
 
 
-secretase activity (Yu et
al., 2000; Chung and Struhl, 2001; Levitan et al., 2001; Ed-
bauer et al., 2002; Hu et al., 2002; Lopez-Schier and
Johnston, 2002). Nct is a type I transmembrane protein
containing multiple glycosylation sites. In mammalian cells,
it is present in an immature, endoglycosidase H (endoH)–
sensitive N-glycosylated form, and a mature, endoH-resis-
tant N-glycosylated form (Edbauer et al., 2002; Leem et al.,
2002). In 
 
Drosophila
 
, Nct might stabilize PS fragments (Hu
et al., 2002; Lopez-Schier and Johnston, 2002) and seems to
be involved in transport of PSs to the cell surface (Chung
and Struhl, 2001). These results suggested to us that a small,
but biologically active, fraction of PS bound to Nct could be
released from the ER and targeted to the cell surface, where
it interacts with the 
 
 
 
-secretase substrates. We therefore in-
vestigated the subcellular localization of PS1 and its binding
partner Nct. Indeed we found PS1 on the plasma membrane
(PM). We also found that PS1 binds to mature, cell surface–
localized Nct. Moreover, inactivation of PSs by mutagenesis
of the critical aspartates or treatment with 
 
 
 
-secretase inhibi-
tors affected cell surface reinternalization and PM accumula-
tion of 
 
 
 
APP. Our data suggest that a PS1–Nct complex is
released from the ER and transported to late Golgi compart-
ments and the cell surface, where it is biologically active.
 
Results
 
Expression of functional EGFP-tagged presenilin
 
To prove if PSs can reach the PM, we chose an approach that
is highly sensitive and independent of fixation methods and
antibody affinity. We tagged PS1 and a previously character-
ized nonfunctional PS1 D385N (Steiner et al., 1999c; Wolfe
et al., 1999b) derivative with EGFP. The EGFP cassette was
inserted into the large cytoplasmic loop within a region previ-
ously shown to be irrelevant for PS function in 
 
 
 
-secretase
activity (Saura et al., 2000; Fig. 1 A). The cDNA constructs,
PS1–EGFP (PE) and PS1 D385N–EGFP (PEASP) were sta-
bly transfected into human embryonic kidney (HEK) 293
cells expressing Swedish mutant 
 
 
 
APP (Citron et al., 1992).
Selected cell lines were then investigated for the functional/
nonfunctional expression of PE and PEASP. We first ana-
lyzed if the fusion proteins could still replace endogenous
PS1 and PS2, a phenomenon closely associated with PS sta-
bilization and complex formation (Thinakaran et al., 1997).
Consistent with previous results (Thinakaran et al., 1997),
expression of PE and PEASP fully replaced endogenous PS1
and PS2 without allowing robust overexpression (Fig. 1 B;
for calculation of overexpression see Materials and methods).
As endogenous PS1 (Thinakaran et al., 1996), PE under-
goes endoproteolysis and an 
 
 
 
50-kD CTF (PE
 
CTF
 
) is gener-
ated (Fig. 1 B). The molecular mass of this fragment corre-
sponds to the molecular mass of the authentic PS1
 
CTF
 
 (
 
 
 
20
kD) plus the fused EGFP (
 
 
 
30 kD). In contrast, PEASP
does not undergo endoproteolysis and accumulates as a full-
length protein (Fig. 1 B), as shown previously for the PS1
D385N mutation (Steiner et al., 1999a; Wolfe et al., 1999b).
We next investigated if PE allows normal A
 
 
 
 production and
if PEASP blocks 
 
 
 
-secretase activity. As shown in Fig. 1 C,
A
 
 
 
 production in cells expressing PE or endogenous PS1/
PS2 is very similar. In contrast, PEASP significantly reduces
A
 
 
 
 production as expected (Fig. 1 C). Reduced A
 
 
 
 produc-
tion is accompanied by the accumulation of 
 
 
 
APP CTFs (De
Strooper et al., 1998; Wolfe et al., 1999b), which are the im-
mediate substrates for 
 
 
 
-secretase cleavage. Whereas these
fragments accumulate in cells expressing PEASP, very low
levels of 
 
 
 
APP CTFs are observed in cells expressing PE and
cells expressing endogenous PS1 (Fig. 1 C). If PE is function-
ally like PS1 wild type (wt), it is expected to promote A
 
 
 
production in an A
 
 
 
40/42 ratio of 
 
 
 
9:1 (Selkoe, 1999).
Separation of A
 
 
 
40 and 42 species secreted by PE-expressing
cells shows the expected ratio (Fig. 1 D). Inserting the FAD-
associated L166P mutation into PE leads to dramatically in-
creased A
 
 
 
42 generation (Fig. 1 D). A similar effect on
A
 
 
 
40/42 ratio is also observed when this mutation is inserted
in PS1 wt (Möhlmann et al., 2002). These experiments
clearly indicate that the insertion of EGFP does not affect the
physiological function of PS, whereas single point mutations
at critical residues abolish (in the case of D385N) or modify 
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(in the case of L166P) the function of EGFP-tagged PS1 in a
predicted manner. To further prove functional expression of
PE, we also analyzed Notch endoproteolysis and nuclear
translocation of the Notch intracellular domain (NICD). As
shown in Fig. 1 E, NICD is produced in cells expressing
PE and Notch
 
 
 
E, a constitutively active Notch construct
(Schroeter et al., 1998). In addition, we observed efficient
nuclear translocation of Notch derivatives exclusively in cells
expressing PE, but not in cells expressing PEASP (Fig. 1 F).
In the latter case, Notch
 
 
 
E accumulates on the PM (Fig. 1 F,
right). Taken together, these data demonstrate that expres-
sion of an EGFP-tagged PS1 does not interfere with its phys-
iological and pathological functions. Moreover, these find-
ings suggest that exogenous PS is delivered to the subcellular
compartments, where endogenous PS is active (for the analy-
sis of PM trafficking of endogenous PS see below).
 
Detection of presenilin on the cell surface of living cells
 
We investigated the subcellular distribution of PE using live
cell microscopy. Two different planes of focus are shown in
Fig. 2, A and B, respectively, and enlargements of the boxed ar-
eas are shown in Fig. 2, C–G. PE staining can be clearly seen in
Figure 1. EGFP-tagged PS1 is fully functional. 
(A) Schematic diagram of EGFP-tagged PS1 variants. 
EGFP was cloned at codon 351 into the large 
cytoplasmic loop of human PS1. The endoproteolytic 
cleavage site within the region coded by exon 9 
(black box) is indicated by an arrowhead, and the 
positions of the critical aspartate at position 385 
(mutated in PEASP) and the FAD-associated L166P 
mutation (mutated in PE L166P) by asterisks. (B) PE 
and PEASP replace endogenous PS1 and PS2. 
HEK293 cells stably expressing Swedish  APP and 
PE (left) or PEASP (right) or endogenous PS1 and 
PS2 (PS endo) were analyzed for PS expression by 
a combined immunoprecipitation/immunoblotting 
protocol using antibodies 3027/BI.3D7 (for PS1) 
and 3711/BI.HF5c (for PS2). Molecular weight 
markers in kD are indicated on the left, positions of 
holoprotein and CTFs are indicated on the right. 
Note that PE and PEASP replace endogenous PS. 
(C)  -Secretase function is normal in cells stably 
expressing PE, but greatly reduced in cells stably 
expressing PEASP. Media and lysates of cells 
stably expressing Swedish  APP and PE or PEASP 
or endogenous PS (PSendo) were collected, separated 
on Tris/Tricine gels, blotted on nitrocellulose 
membrane, and probed with antibody 6E10 (A ) or 6687 (APPCTF). (D) The ratio of A  40/42 is not altered by the EGFP tag. Media of cells 
stably expressing Swedish  APP and PE (PE) or PE carrying an FAD-associated L166P mutation (PEL166P) were collected, immunoprecipitated 
with antiserum 3926, separated by electrophoresis (Wiltfang et al., 1997), blotted, and probed with antibody 6E10. A  40/42 production is 
normal in PE-expressing cells, but dramatically changed in PEL166P-expressing cells. (E and F) Cells stably expressing PE support Notch cleavage. 
(E) Cells stably expressing PE and constitutively active Notch E (N E) were pulse labeled for 15 min with 
35S-methionine (0), or pulse labeled 
for 15 min and chased for 60 min (60). Lysates were immunoprecipitated using antibody 9E10 and analyzed by SDS-PAGE and audioradiography. 
Molecular weight markers in kD are indicated on the left, the position of N E and the  -secretase–dependent fragment, NICD, are indicated 
on the right. (F) Cells stably expressing PE or PEASP were transiently transfected with N E, fixed, and processed for immunofluorescence using 
antibody 9E10. In PE cells, staining is seen in the nucleus (arrows), indicating efficient Notch cleavage and translocation of NICD, whereas in 
PEASP cells myc staining is seen on the PM, showing that Notch cleavage is blocked (arrows mark stained filopodia, indicative of PM).
Figure 2. PE is on the surface of living cells. 
HEK293 cells stably expressing Swedish  APP and 
PE were grown on poly-L-lysine–coated coverslips, 
labeled with TRITC–WGA, mounted for live imaging, 
and imaged with a sensitive CCD camera. A and B 
show two different focal planes of a set of living 
cells, and C–G show enlargements of the boxed 
areas. Note the PE staining in the nuclear envelope 
(A and arrow in C), the borders of neighboring 
cells (arrowheads in C and D), and on pseudopod-
like processes (E–G). Ph, phase contrast. Bars, 10  m.554 The Journal of Cell Biology | Volume 158, Number 3, 2002
the nuclear envelope, vesicular structures, and an ER-like net-
work. Surprisingly, the borders of neighboring cells (Fig. 2 C),
marked by staining with fluorescent WGA (TRITC–WGA;
Fig. 2 D) were clearly labeled, suggesting a PM localization of
PE. Another example of surface localization is shown in Fig. 2,
E–G, where a lamellipodium (indicated by phase contrast in
Fig. 2 G) of a cell is labeled with PE (Fig. 2 E) as well as
TRITC–WGA (Fig. 2 F). The observed PM localization of PE
is not an artifact of our detection method, because ER-retained
GFP–KDEL does not show PM staining under identical imag-
ing conditions (Fig. S1, available at http://www.jcb.org/cgi/
content/full/jcb.200201123/DC1).
PEASP was also detected on the PM (Fig. 3, A and B). As
compared with PE, a more prominent staining of the vesicu-
lar structures was observed (compare Fig. 2, A and B, with
Fig. 3, A and B). Most of these vesicular structures can be
stained with lysotracker and antibodies against lamp-2, sug-
gesting that they are endosomes/lysosomes (unpublished
data). However, PEASP is also located in lamellipodia, as
demonstrated in the enlargements, where the focal plane of
attachment to the coverslip is shown (Fig. 3 C). Again, fine
cellular processes shown in the phase image (Fig. 3 E) are la-
beled with PEASP (Fig. 3 C) and TRITC–WGA (Fig. 3 D).
To further prove that significant amounts of PE and
PEASP are on the PM, we performed total internal reflection
microscopy (TIRM). This technique selectively excites fluoro-
phores near the coverslip, whereas fluorophores  100 nm
away (and deeper in the cell) are not excited. Therefore, only
the area where the cell attaches to the coverslip is illuminated,
and obscuring fluorescence from internal structures is dimin-
ished (for review see Toomre and Manstein, 2001). We per-
formed TIRM on living PE- or PEASP-expressing cells (Fig.
4). The TIRM images on the left show the PM of both PE
and PEASP cells, best visible in the lamellipodia indicated by
arrows. Both PE and PEASP show a similar degree of PM
staining. The pronounced vesicular staining observed for
PEASP (compare Figs. 2 and 3) is also visible to some extent
in the TIRM image, suggesting that some of these vesicles are
Figure 3. PEASP is on the surface of living cells. 
Cells stably expressing PEASP were grown on poly-
L-lysine–coated coverslips, labeled with TRITC–
WGA, mounted for live imaging, and imaged with 
a sensitive CCD camera. A and B show two different 
focal planes of a set of living cells, and C–E show 
enlargements of the boxed area. Note the PEASP 
staining of the nuclear envelope and vesicular 
structures (A), and of pseudopod-like processes (C–E, 
arrows). Ph, phase contrast. Bars, 10  m.
Figure 4. Cell surface localization of PE and 
PEASP visualized by TIRM. Living cells stably 
expressing PE or PEASP and grown in poly-L-
lysine–coated glass bottom dishes were imaged 
using TIRM on the left or using conventional 
epifluorescence (epi) on the right. Arrows indicate 
labeled lamellipodia and filopodia, indicative of 
PM. Bar, 10  m. A PS1–nicastrin complex is at the plasma membrane | Kaether et al. 555
very close to the PM. Right panels show conventional epifluo-
rescence of the same cells. As a control, we performed TIRM
on living HEK293 cells stably expressing GFP–KDEL. No
staining of the PM could be detected under identical imaging
conditions (Fig. S2). Taken together, these data suggest that
significant amounts of PS1 are located at the PM.
Although we clearly demonstrated that the EGFP-tagged
PS derivatives showed the expected functional properties, we
performed further experiments with untagged PS1 to sup-
port the above described data with direct biochemical evi-
dence. In addition, we also analyzed PM targeting of en-
dogenous PSs. Cell lines expressing endogenous PSs, PE,
PEASP, PS1 wt, or PS1 D385N (Steiner et al., 1999c) were
biotinylated at 4 C. Biotinylated proteins were isolated and
PSs were detected by immunoblotting using antibodies to
the COOH and NH2 termini, respectively. As shown in Fig.
5, we detected biotinylated PECTF, NH2-terminal fragment
of PE (PENTF), PE, and PEASP holoprotein, PS1CTF and
PS1NTF as well as PS1 holoprotein, suggesting that all PS de-
rivatives were at the PM. Importantly, endogenous PS1NTF
and PS1CTF can be biotinylated at the PM (Fig. 5). Because
endogenous PS holoprotein is efficiently processed to
PS1NTF and PS1CTF (Thinakaran et al., 1996), it could not
be detected by biotinylation. Moreover, the ratio of surface/
internal PS of roughly 1/30 is not changed upon overexpres-
sion of PS derivatives (see Materials and methods). This
strongly indicates that overexpression of PS does not change
its subcellular distribution. As a control for selective cell sur-
face biotinylation, we immunoblotted the isolated biotiny-
lated proteins with an antibody to early endosomal autoanti-
gen 1 (EEA1; a protein localized to early endosomes). As
Figure 5. PS1 can be biotinylated at the cell surface. HEK293 
cells stably expressing Swedish  APP and PE, PEASP, PS1 wt, PS1 
D385N, or endogenous PSs were surface biotinylated. After 
streptavidin precipitation, biotinylated proteins and cell lysates 
(1/60 of total) were separated using SDS-PAGE, blotted, and probed 
for PS1 CTF (A), and stripped and reprobed for PS1 NTF (B). Note 
that PE CTF and PS1 holoprotein (o) have similar molecular weights. 
Asterisks indicate unspecific background bands. To control for 
intactness of cells during the biotinylation, the blot was stripped and 
reprobed for EEA1 (C). No EEA1 staining can be detected on the 
streptavidin-precipitated material (left, biotinylation), whereas cell 
lysates contain robust amounts of EEA1 (right, lysate).
Figure 6. Mature Nct interacts with endogenous PS at the PM. 
(A) HEK293 cells expressing endogenous PSs and endogenous Nct 
were surface biotinylated, lysed, separated using SDS-PAGE, blotted, 
and probed for Nct. Biot, streptavidin-Sepharose precipitation; lys, 
1/100 of cell lysate; Nctim, immature Nct; Nctm, mature Nct. To control 
for intactness of cells during the biotinylation, the blot was stripped 
and reprobed for GSK-3 ( GSK), and stripped and reprobed for 
EEA1 ( EEA1). Neither GSK-3 nor EEA1 staining can be detected on 
the streptavidin-precipitated material (biot), whereas cell lysates 
contain robust amounts of GSK-3 and EEA1 (lys). The GSK antibody 
is reactive with GSK-3  (upper band) and GSK-3  (lower band). 
Identical results were obtained from cells expressing exogenous PS1 
wt (unpublished data). (B) Coimmunoprecipitation of endogenous 
PS1 and mature Nct. HEK293 cells expressing endogenous Nct and 
PSs were lysed in 2% CHAPS, and immunoprecipitated with an Nct 
antibody (IP Nct) or PS1 antiserum 3027 (IP PS1). Immunoprecipitates 
were digested with endoH (IP PS1, H) or N-glycosidase F (IP PS1, F). 
(C) Coimmunoprecipitation of endogenous PS1 and biotinylated 
endogenous Nct. HEK293 cells expressing endogenous Nct and 
endogenous PSs were subjected to surface biotinylation with ( ) or 
without ( ) biotin. Membrane fractions were prepared, lysed in 2% 
CHAPS, immunoprecipitated with antiserum 3027 against PS1 CTF, 
eluted, and the eluate was precipitated with streptavidin-Sepharose 
(strep). Samples were separated on SDS-PAGE together with a 
control cell lysate (lys) and 15  l of the streptavidin-Sepharose 
supernatants (sup). Blots were probed with the Nct antibody. Note 
that the supernatant of the biotinylated lysate contains less Nct 
because biotinylated Nct was streptavidin precipitated. Nctim, 
immature Nct; Nctm. mature Nct; NctHres, endoH-resistant Nct; Nctdegly, 
deglycosylated Nct.556 The Journal of Cell Biology | Volume 158, Number 3, 2002
expected, no biotinylated EEA1 was observed, although the
investigated cell lines express significant amounts of this in-
tracellular protein (Fig. 5, bottom).
A PS1–Nct complex is targeted to the PM
An additional line of evidence for cell surface trafficking of
PS1 was obtained by the analysis of the PS1 binding protein
Nct. Nct is an essential component of the PS complex, and
is required for  -secretase activity (Yu et al., 2000; Chung
and Struhl, 2001; Levitan et al., 2001; Edbauer et al., 2002;
Hu et al., 2002; Lopez-Schier and Johnston, 2002). We
therefore analyzed Nct trafficking through the secretory
pathway and its interaction with PS1. Importantly, the en-
tire analysis was performed with cells expressing endogenous
PSs and Nct. Endogenous Nct is present predominantly in a
mature and, to a lesser extent, an immature form (Fig. 6 A,
 Nct, lys). Cell surface biotinylation demonstrated that the
mature form is present on the PM, demonstrating that Nct
can leave the ER only upon full maturation (Fig. 6 A,  Nct,
biot). Cells were intact during the biotinylation, as indicated
by reprobing the blot with antibodies against glycogen syn-
thase kinase 3 (GSK-3) and EEA1 (Fig. 6 A,  GSK,
 EEA1). To analyze if immature or mature Nct interacts
with PS1, we performed a coimmunoprecipitation of Nct
with PS1 antibodies followed by deglycosylation (Fig. 6 B,
IP PS1). As a control, cell lysates were immunoprecipitated
using Nct antibodies (Fig. 6 B, IP Nct). Immunoprecipita-
tion with PS1 antiserum 3027 preferentially coprecipitates
mature Nct (Fig. 6 B,  ). The coimmunoprecipitated Nct
is endoH resistant, as digestion with endoH leads only to a
minor shift to higher mobility (Fig. 6, B and H). This minor
shift is most likely explained by incomplete glycosylation of
some of the many N glycosylation sites (Leem et al., 2002).
In contrast, the immature form of Nct is shifted upon en-
doH digestion to the position of the totally deglycosylated
Nct (Fig. 6 B, lanes H and F). These data demonstrate that
endogenous PS1 bound to endogenous Nct reached late
Golgi compartments, where complex glycosylation occurs.
We next analyzed whether the PS1–Nct complex is tar-
geted to the cell surface. To this end, we performed surface
biotinylation followed by coimmunoprecipitation of Nct us-
ing PS1 antibodies. Bound proteins were eluted, subjected
to streptavidin-Sepharose precipitation, and detected using
Nct antibodies (Fig. 6 C). Indeed, biotinylated mature Nct
was coimmunoprecipitated with PS1 (Fig. 6 C, strep
 ). No
Nct was detected when the biotin was omitted (Fig. 6 C,
strep
 ). The supernatant of the streptavidin-Sepharose pre-
cipitation showed that Nct was coimmunoprecipitated with
or without biotin (Fig. 6 C, sup). These results demonstrate
that PS1 and Nct are present in a complex at the PM.
Functional inactivation of presenilin affects trafficking 
of cell surface  APP
After demonstrating targeting of a PS1–Nct complex to the
PM, we wanted to investigate whether inactivation of PS
would also affect cellular mechanisms other than A  produc-
tion. To this end, we investigated endocytosis of  APP in
living cells expressing either fully functional PS1 or the non-
functional PS1 D385N mutant. Cells expressing either PS1
wt or PS1 D385N (Fig. 7) were incubated on ice with anti-
serum 5313 recognizing the ectodomain of  APP, washed,
and returned to 37 C. After the indicated time points, cells
Figure 7. Endocytosis of  APP, but not 
BACE, is delayed in cells expressing 
nonfunctional PS1. HEK293 cells stably 
expressing Swedish  APP and PS1 wt or 
PS1 D385N were incubated on ice with 
antiserum 5313, washed, and chased at 
37 C. Cells shown in the third row were 
additionally treated for 4 h with DAPT. 
Cells stably expressing BACE were 
incubated on ice with antiserum 7523, 
washed, and chased at 37 C. After the 
indicated time points, cells were fixed 
and processed for immunofluorescence. 
Bar, 10  m. A PS1–nicastrin complex is at the plasma membrane | Kaether et al. 557
were fixed and processed for immunofluorescence. In PS1
wt–expressing cells, cell surface  APP was completely taken
up after 10 min (Fig. 7). In contrast,  APP was present
much longer on the surface of cells expressing PS1 D385N.
After 10 min at 37 C, an unchanged surface staining of
 APP was observed and there were no endocytic structures
containing  APP. Only after 20–30 min did  APP-contain-
ing endocytic structures become visible, but no complete up-
take was observed at these time points (Fig. 7).
Next we tested if other  APP interacting type I trans-
membrane proteins are also delayed in reinternalization
upon the expression of functionally inactive PS1 D385N.
We investigated endocytosis of BACE, a molecule previ-
ously shown to be reinternalized from the cell surface (Huse
et al., 2000; Walter et al., 2001). This revealed that endocy-
tosis of BACE was not affected (Fig. 7), indicating that inac-
tivation of PS1 does not have a general effect on the endocy-
tosis of proteins involved in  APP metabolism.
To further prove that inactivation of a PS-dependent  -secre-
tase activity affects reinternalization of  APP, we used the
highly specific  -secretase inhibitor DAPT (Dovey et al.,
2001). Incubation of cells with DAPT leads to biochemical
phenotypes very similar to those observed in PS1 D385N–
expressing cells (Dovey et al., 2001; Sastre et al., 2001), i.e.,
inhibition of A  and  APP intracellular domain production,
enrichment of  APP CTFs, and inhibition of NICD genera-
tion accompanied by a lack of Notch signaling (Geling et al.,
2002). Cells expressing PS1 wt were incubated for 4 h with
DAPT and processed for  APP uptake as above. Endocytosis
of  APP was delayed, and significant levels of surface  APP
were still present at the PM after 10 min at 37 C. After 20
and 30 min at 37 C, most of the  APP had been endocy-
tosed, however, at all time points, there were cells present
with surface-retained  APP (Fig. 7). Similar, albeit weaker,
effects were observed using a different  -secretase inhibitor
(Li et al., 2000b; unpublished data). These data therefore
demonstrate that functional inactivation of a PS1-associated
 -secretase activity not only affects  APP processing but also
its trafficking from the cell surface to endosomes.
The delay in endocytosis was also observed in cells ex-
pressing functionally inactive PS2 D366A, demonstrating
similar activities of nonfunctional PS1 and PS2 (Fig. 8). Im-
portantly, inactivation of endogenous PSs with DAPT re-
sulted in a delayed endocytosis of  APP, very similar to the
results observed with PS-transfected cells (Fig. 8).  APP-
expressing HEK293 and COS7 cells were incubated in the
presence or absence of DAPT and processed for  APP up-
take as above (Fig. 8). In both cell lines, the inactivation of
endogenous PSs resulted in delayed endocytosis of  APP,
fully reproducing the findings observed in transfected cells.
If reinternalization of  APP is delayed, one should obtain el-
evated levels of cell surface  APP in cells expressing the non-
Figure 8. Endocytosis of  APP is delayed in 
cells expressing nonfunctional PS2 or 
endogenous PSs. HEK293 cells stably expressing 
Swedish  APP and PS2 wt or PS2 D366A, 
and HEK293 cells expressing  APP695 and 
endogenous PS1 and PS2 (PS endo) as well as 
COS7 cells transiently transfected with 
 APP695 (COS7) were incubated for 4 h in the 
presence or absence of DAPT. Thereafter, 
they were incubated on ice with antiserum 
5313, washed, and chased at 37 C. After the 
indicated times, cells were fixed and processed 
for immunofluorescence. Bar, 10  m.558 The Journal of Cell Biology | Volume 158, Number 3, 2002
functional PS1 D385N variant. To prove this, we surface bio-
tinylated  APP. Biotinylated  APP was quantified using 
125I-
labeled secondary antibodies. Consistent with previous data
(Kim et al., 2001), PS1 D385N–expressing cells showed 2.8  
1 (n   8) times more  APP on the surface than cells express-
ing PS1 wt. This suggests that indeed  APP accumulates on
the cell surface, probably due to delayed reinternalization.
Loss of PS function, but not FAD mutants or uncleavable 
PS mutants, affects reinternalization of  APP
The above-described results suggest that a loss or reduction
of PS function is responsible for the observed reduction of
 APP reinternalization. To prove if a gain of misfunction,
which apparently is caused by all FAD mutations, affects
surface metabolism of  APP, we analyzed two FAD-associ-
ated PS mutations. We chose the PS1 G384A mutation, be-
cause this mutant shows an exceptional 5.5-fold increase of
A 42 generation (Steiner et al., 2000). In addition, we also
included the PS1  E9 mutation, because that produces high
A 42 levels, but in addition accumulates as an uncleaved
holoprotein (like the PS1 D385N and PS2 D366A mutants)
(Thinakaran et al., 1996). Because the PS1  E9 may mimic
a cleaved PS derivative (Ratovitski et al., 1997; Capell et al.,
1998; Steiner et al., 1999b), we also investigated a previ-
ously characterized PS1 M292D point mutation, which in-
hibits endoproteolysis (Steiner et al., 1999c). Expression of
any of these PS variants allowed normal uptake of  APP,
suggesting that a loss or reduction of PS function, but not a
gain of pathological function, is responsible for the observed
defects in endocytosis (Table I).
Discussion
The functional role of PSs in  -secretase cleavage of  APP is
currently unclear. Two controversial models are discussed.
The first model suggests that PSs contribute the catalytically
active sites of a  -secretase complex or at least an essential
cofactor of it (Wolfe et al., 1999b; Wolfe and Haass, 2001).
In the second model, an indirect role of PSs in trafficking,
rather than processing, of  APP is assumed (Kim et al.,
2001). Support for the latter comes from studies that dem-
onstrate that  APP and  APP CTFs are enriched on the
surface of cells expressing functionally inactive PS (Capell et
al., 2000a; Kim et al., 2001). Moreover, the subcellular dis-
tribution of PSs apparently does not overlap with the cellu-
lar sites of  -secretase activity in late compartments at or
close to the cell surface, a finding that created the so-called
spatial paradox (Annaert et al., 1999; Checler, 2001; Cupers
et al., 2001). This model implies that PSs are required to re-
lease  -secretase activity from early transport compartments,
but in its ultimate consequence predicts a  -secretase com-
plex, which functions without physical contact to PS.
Considering these two contradictory models, we first re-
evaluated the cellular distribution of PS1. Endogenously as
well as exogenously expressed PS1 was biochemically de-
tected on the PM. Moreover, we found that  -secretase ac-
tivity and PS1 codistributed in a post trans-Golgi compart-
ment in MDCK cells (unpublished data). Furthermore, we
could clearly demonstrate that an EGFP-tagged PS1 local-
izes on the PM in living cells. It is highly unlikely that the
fusion of the EGFP domain changed trafficking of PS1, be-
cause we could demonstrate that such PS derivatives are fully
functional and can be inactivated by the introduction of the
D385N mutation as expected. Independent support for a
PM localization of PS1 comes from the coimmunoprecipita-
tion of Nct with PS1. Preferentially mature, fully glycosy-
lated Nct associates with PS1, indicating that a PS1–Nct
complex is targeted to a post-Golgi compartment. Like PS1,
a fraction of Nct can be biotinylated at the PM. Moreover,
biotinylated endogenous Nct could be coimmunoprecipi-
tated with endogenous PS1, strongly suggesting that a PS1–
Nct complex is located at the PM.
In addition to our findings on PS localization in a late
Golgi compartment and at the cell surface, we found that
inactivation of both endogenous and exogenous PS func-
tion affects the endocytosis of  APP from the PM. There-
fore, it appears likely that PSs have a dual function in traf-
ficking and processing. Based on a quantitative analysis, we
calculated that  1/30 of total PS is located on the PM.
From these data, we conclude that rather small amounts of
PSs could indeed exert a biological activity at or very close
to the PM. It is not known how much active PS complex is
needed for functional  -secretase activity. However, assum-
ing a catalytic activity of the complex, the amounts of PS1
we found on the PM could well account for the cleavage of
 APP, Notch, ErbB4, E-cadherin, and LDL receptor-like
protein and other so far unidentified  -secretase substrates.
Our data on the surface localization of PS1 are therefore in
full accordance with PSs being part of the proteolytically ac-
tive  -secretase complex.
It is unclear why conventional immunolabeling tech-
niques did not allow the detection of PSs beyond the inter-
mediate Golgi apparatus. However, GFP fluorescence in our
constructs is rather weak, suggesting low expression levels,
and thus sensitive detection methods are required to visual-
ize PS. In agreement with previous reports (Walter et al.,
1996; De Strooper et al., 1997; Annaert et al., 1999; Cupers
et al., 2001), in our hands, most of PS seems to be located in
the ER, sometimes masking the weak staining on the PM. It
is also important to note that upon fixation, the GFP fluo-
rescence is significantly reduced (unpublished data), which
makes the detection of surface PS very difficult.
Our data demonstrate that trafficking of  APP is altered
in cells expressing nonfunctional PS1, whereas the traffick-
Table I. Endocytosis of APP in cell lines expressing different
PS variants
Cell line DAPT
  DAPT
 
HEK293/APPswe/PS1 wt N D
HEK293/APPswe/PS1 D385N D
HEK293/APPswe/PS2 wt N
HEK293/APPswe/PS1 D266A D
HEK293/APPswe/PS endo N D
HEK293/APP/PS endo N D
COS7/APP N D
HEK293/APPswe/PS1 G384A N
HEK293/APPswe/ PS1  E9 N
HEK293/APPswe/PS1 M292D N
APP uptake experiments were performed as described in Fig. 7. APPswe,
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ing of another  APP processing enzyme, BACE, is unaf-
fected. The accumulation of  APP CTFs on the surface
(Capell et al., 2000a; Kim et al., 2001) could simply reflect
accumulation of the precursor of  -cleavage, because this
cleavage is blocked. However, accumulation of full-length
 APP on the surface indicates an effect on trafficking, inde-
pendent of the role of PSs in  -secretase function (this
study; Kim et al., 2001). The cellular mechanism responsi-
ble for the surface accumulation of  APP could be the de-
layed reinternalization due to the saturation by the accumu-
lation of APP and its derivatives on the PM. Indeed, we
found that  APP endocytosis is slowed down in cells ex-
pressing nonfunctional PS1 or PS2, which would lead to an
accumulation of surface  APP if exocytic transport is unal-
tered. In line with unaltered exocytosis, it has been shown
that maturation of  APP is not affected in cells expressing
nonfunctional PS1 (Wolfe et al., 1999b).
Taken together, our data demonstrate that a small, but
functionally active, fraction of PS1 bound to Nct is released
from the ER and targeted to the PM. In agreement with the
spatial paradox, the majority of PS1 is retained within the
ER, where little  -secretase activity is observed. However, in
clear contrast to the proposals of the spatial paradox, a frac-
tion of PS1 (bound to Nct) is located within a post-Golgi
compartment and at the PM. A function of PS on the cell
surface is supported by our finding that inactivation of PSs
by two independent methods slows endocytosis of  APP
from the PM. The loss of PS function may indirectly affect
 APP uptake due to a toxic gain of misfunction. This is sup-
ported by our previous finding that the aspartate mutants of
PS cause a massive accumulation of  APP CTFs (Capell et
al., 2000a), which cannot only be explained by the loss of
 -secretase activity, but rather by reduced degradation. The
latter may very well be due to reduced endosomal/lysosomal
targeting of the  APP CTFs, resulting in their accumulation
on the cell surface (Capell et al., 2000a; Kim et al., 2001).
Our data suggest a dual function for PSs: they may be in-
volved in the trafficking of  APP, via so far unidentified
mechanisms, and in the  -secretase processing of  APP by
providing the catalytically active sites within the  -secretase
complex. Both functions are apparently related to the forma-
tion of a PS–Nct complex, which may contain other addi-
tional subunits, such as aph-1 (Goutte et al., 2002). In fact,
absence of Nct (Yu et al., 2000; Chung and Struhl, 2001;
Levitan et al., 2001; Edbauer et al., 2002; Hu et al., 2002;
Lopez-Schier and Johnston, 2002) and aph-1 (Goutte et al.,
2002) severely affects  -secretase activity.
Materials and methods
Antibodies and cell lines
Antiserum 7523 against the NH2 terminus of BACE was described before
(Capell et al., 2000b). A ,  APP, and  APP CTFs were detected using an-
tibodies 3926/6E10 (Sastre et al., 2001), 5313, and 6687 (Steiner et al.,
2000), respectively. The PS1 CTF was immunoprecipitated with antise-
rum 3027 and detected with monoclonal BI.3D7 or 3027 as previously
described (Steiner et al., 1999b). The PS1 NTF was detected using the
monoclonal PS1 N antibody (provided by R. Nixon, Nathan Kline Insti-
tute, Orangeburg, NY). The PS2 CTF was immunoprecipitated with anti-
serum 3711 and detected with monoclonal BI.HF5c as previously de-
scribed (Capell et al., 1998). EEA1 was detected using the monoclonal
EEA1 antibody (Sigma-Aldrich). Notch E (Schroeter et al., 1998) and
NICD were detected using monoclonal 9E10 antibody (Santa Cruz Bio-
technology, Inc.). Nct was detected using polyclonal anti-Nct COOH-
terminal antibody (Sigma-Aldrich). GSK-3 was detected using mono-
clonal antibody against GSK-3  (Santa Cruz Biotechnology, Inc.).
HEK293 cells stably expressing Swedish mutant  APP (Citron et al.,
1992) and PS1 wt, PS1 D385N, PS2 wt, or PS2 D266A were described
before (Steiner et al., 1999a,c). HEK293 cells stably expressing Swedish
mutant  APP and PS1 wt or PS1 D385N were transfected with BACE
cDNA in pcDNA3.1/Hygro
  (Invitrogen) and pools of stably expressing
cells were selected.
cDNA constructs, transfections, and screening of stably 
transfected cell lines
To generate an EGFP-tagged PS, a NotI restriction site was introduced be-
tween codon 351 and 352 of the cytoplasmic loop of human PS1, resulting
in PS1not. EGFP cDNA was then fused in-frame into the PS sequence using
the NotI site. Introduction of the NotI site results in two additional glycine
codons at NH2 and COOH termini of EGFP, respectively. Proper orienta-
tion of EGFP was checked by transfecting miniprep DNA into COS7 cells
and analyzing GFP fluorescence. One clone, PE, was subcloned in
pCDNA3.1Zeo (Invitrogen). PS1 D385N–EGFP and PS1 L166P–EGFP were
generated by mutagenizing PE with appropriate oligonucleotides using
QuikChange Site-Directed Mutagenesis Kit (Stratagene). The former con-
struct was called PEASP, the latter PE (L166P).
For transient or stable transfection, Fugene (Roche) was used. HEK293
cells stably expressing Swedish  APP were transfected with PE or PEASP or
PE (L166P) and clones were selected for stable integration. Several clones
expressing each construct were analyzed and one representative clone
was chosen for further analysis. PE17 was the clone used for analysis of PE,
and PEASP1 was the one used for PEASP. For analysis of Notch processing,
PE 17 cells were transfected with Notch E/pcDNA3.1/Hygro
 , and a pool
of stably expressing cells was obtained by selection with hygromycin. Al-
ternatively, PE 17 cells were transfected and processed for immunofluores-
cence the following day.
As a control for microscopy, HEK293 cells were transiently transfected
with pEF/myc/ER/GFP (Invitrogen), coding for a GFP–KDEL. For APP up-
take experiments, COS7 cells were transiently transfected with  APP695.
Quantitation of expression levels of exogenous PS
For quantitating membrane lysates (Capell et al., 1998) and total lysates of
HEK293, cells expressing endogenous PSs or stably expressing PS1 wt or PE
were separated on 12% urea gels, blotted, and probed with antiserum
3027. Expression levels were quantitated using 
125I secondary antibodies
and a phosphoimager system. Total exogenous PS (holoprotein and CTF)
was overexpressed 10-fold, compared with endogenous PS1 levels. Only a
twofold overexpression of exogenous PS CTF was observed. Because the bi-
ologically active PS complex contains the PS fragments (Capell et al., 1998;
Li et al., 2000a), this demonstrates a rather low level of overexpression.
Surface biotinylation
HEK293 cells grown on poly-L-lysine–coated 10-cm (for PS and Nct detec-
tion) or 6-cm dishes (for APP detection) were washed in ice cold PCM (PBS
supplemented with 1 mM CaCl2, 0.5 mM MgCl) and incubated for 30
min on ice in PCM containing 1 mg/ml (for PS and Nct) or 0.5 mg/ml (for
 APP) sulfo-succinimidyl-6-([ ]-biotinamido)-hexanoate (Molecular Bio-
sciences). Thereafter, biotinylation was quenched by washing two times in
50 mM NH4Cl–PBS on ice, followed by a 10-min incubation on ice in 50
mM NH4Cl–PBS. In some experiments, 20 mM glycine–PBS was used for
quenching. After two additional washes, cells were lysed in STEN lysis
buffer (50 mM Tris, pH 7.6, 150 mM NaCl, 2 mM EDTA, 1% NP-40), and
biotinylated proteins were precipitated with streptavidin-Sepharose. Bio-
tinylated proteins and 1/60 of total cell lysates were separated on 12% SDS-
urea gels (PS) or 8% SDS gels ( APP and Nct) and blotted onto PVDF
membranes. PS1 was detected using antibodies 3027 or PS1 N, Nct using
anti-Nct antibody, and  APP using antiserum 5313. As a control, blots
were stripped and reprobed with EEA1 or GSK-3 antibody. Similar blots to
those shown in Fig. 5 were incubated with 
125I secondary antibodies, and
the radioactive signal was detected using a phosphoimager system. The ra-
tio of biotinylated versus total PS was then calculated.
Quantitation of cell surface  APP
For quantitation of surface  APP, cells were biotinylated as described
above. Biotinylated  APP was detected using antiserum 5313 and 
125I sec-
ondary antibody and quantified by phosphoimaging. In each experiment,
the values of biotinylated  APP divided by total  APP of PS1 wt–express-
ing cells were set to 1, and the values of biotinylated  APP divided by total
 APP of PS1 D385N–expressing cells was related to 1.560 The Journal of Cell Biology | Volume 158, Number 3, 2002
Coimmunoprecipitation and deglycosylation of Nct
Nct was coimmunoprecipitated from membrane fractions extracted in 2%
CHAPS with antiserum 3027 against PS CTF (Capell et al., 1998). EndoH
and N-glycosidase F digestion was performed according to the supplier’s
instructions (Roche). For coimmunoprecipitation and recapture of biotin-
ylated Nct CHAPS lysates from the cell surface, biotinylated cells were im-
munoprecipitated with antiserum 3027 against PS CTF. Bound proteins
were eluted from protein A–Sepharose as described (Bonifacino et al.,
2000), and biotinylated proteins were precipitated using streptavidin-
Sepharose. Nct was detected using Nct antibody.
Cell surface uptake of  APP and BACE
Cells plated on poly-L-lysine–coated coverslips were incubated for 4 h in
the presence or absence of 250 nM DAPT (provided by Boehringer Ingel-
heim Pharma KG), washed in ice cold PCM, and incubated on ice in a
1:200 5313 (for  APP detection) or 7523 (for BACE detection) antibody dilu-
tion in PCM. After 20 min, cells were washed in PCM on ice, and then
PCM was replaced by prewarmed culture medium and cells were placed
for various time points in a 37 C incubator. After indicated time points,
coverslips were transferred to 4% paraformaldehyde, 4% sucrose in PBS,
fixed for 20 min, and processed for standard immunofluorescence (Wacker
et al., 1997) using Alexa
®488- or Alexa
®594-coupled secondary anti–rab-
bit antibodies (Molecular Probes). Endocytosis of  APP or BACE was nor-
mally fully completed after 10–20 min, depending on the individual exper-
iment. Experiments were performed at least twice, and 50–100 cells were
scored per cell line and time point. Representative images are shown.
Microscopy
Fixed cells were analyzed on a Leica DMRB microscope equipped with a
100x/1.3 objective and standard FITC and TRITC fluorescence filter sets.
Images were obtained using a Spot Camera (RT Monochrome Diagnostics)
and the MetaView Imaging software (Universal Imaging Corp.). For analysis
of living cells, cells were cultured on poly-L-lysine–coated coverslips and
mounted on custom-made aluminum holders. For labeling of the PM, cells
were incubated for 20 min on ice in 20  g/ml TRITC–WGA/PCM (Sigma-
Aldrich) followed by a wash in ice cold PBS. Imaging was performed on an
Olympus IX70 microscope using a 60   1.4 Planapo objective and a GFP/
Texas red double dicroic emission filter. Images were recorded with a TILL
Vision setup consisting of a TILL Imago camera, Polychrome IV monochro-
mator, and Vision software (T.I.L.L. Photonics GmbH). The EGFP fluores-
cence in general was very low; typical exposure times ranged from 1–4 s. In
cells labeled with TRITC–WGA, special care was taken to avoid excitation
of TRICT–WGA when viewing GFP. Excitation with 480–490 nm led to
considerable excitation of TRITC–WGA, leading to a bleedthrough of the
red fluorescence (due to the double dicroic filter used). Control experiments
revealed that excitation with 470 nm showed only GFP, but no TRITC fluo-
rescence, even in very long exposures. Images therefore were recorded
with an excitation of 470 nm for GFP and 570 nm for TRITC–WGA.
TIRM
PE or PEASP cells were grown in poly-L-lysine–coated glass bottom dishes
(MatTek Corporation). TIRM was performed on an objective type setup
based on an inverted microscope (Olympus IX70) equipped with an oil im-
mersion objective (PlanApo  60, NA 1.45 TIRFM; Olympus). The specimen
was illuminated with an argon laser (model 163-All; Spectra Physics). Im-
ages were recorded on an Imago CCD sVGA camera using Vision software.
Online supplemental material
The supplemental figures for this article are available at http://www.jcb.org/
cgi/content/full/jcb.200201123/DC1. To exclude the possibility that the de-
tection of PS–EGFP at the cell surface is not an artifact of overexpression, we
analyzed the subcellular distribution of an overexpressed ER-resident protein.
For this, a GFP–ER with a KDEL retention motif was expressed in HEK293
cells and analyzed by conventional fluorescence microscopy (Fig. S1) and
TIRM (Fig. S2). No staining of the plasma membrane could be detected.
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